The numbers are impressive. $5,000 for one Instagram post. $8,900 for a single YouTube video. $13,644 in one month for affiliate marketing deals on TikTok.
Keep Reading →
July 2 - Hedge Funds, Insider Trading
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Keep Reading →
December 14 - Lists, News
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News
If you're looking to lose weight, we've compiled a list of 7 medically proven weight loss supplements that work. As summer is already here, if you slacked off throughout the...
Keep Reading →
June 17 - News
"U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.
Keep Reading →
May 30 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
Keep Reading →
April 12 - Lists, News
The 10 least obese countries in the world are mostly from Asia and Africa.
Keep Reading →
March 26 - Lists, News
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
Keep Reading →
March 15 - Lists, News
Peltz is that rare breed of insurgent known as "operational activists" because his track record as an operator sets him apart from "financial activists," investors from a hedge...
Keep Reading →
March 13 - Hedge Funds
Most HIV patients have no options in regard to how they must consume their medication.
Keep Reading →
February 14 - News, Stock Analysis
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug Administration.
Keep Reading →
February 2 - News, Stock Analysis
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Keep Reading →
January 26 - Lists, News
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
NeRRe Therapeutics, which is a GlaxoSmithKline PLC (ADR) (NYSE:GSK) spinout, has raised £23 million ($28 million) in a Series B financing round.
Keep Reading →
January 6 - News, Stock Analysis
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
Keep Reading →
December 30 - Lists, News
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
Keep Reading →
December 21 - News, Stock Analysis
The National Institute for Health and Care Excellence (NICE) has confirmed the approval of a new injectable asthma drug from GlaxoSmithKline PLC (ADR) (NYSE:GSK).
Keep Reading →
December 2 - News, Stock Analysis
GlaxoSmithKline plc (ADR) (NYSE:GSK) has moved to expand the target market for its blockbuster vaccine, Shingrix, with the filing of a regulatory application in Europe.
Keep Reading →
November 30 - News, Stock Analysis
Theravance Biopharma Inc (NASDAQ:TBPH) just put out an announcement relating to its closed triple asset, and the company is trading flat-to-down despite the seemingly positive...
Keep Reading →
November 22 - News, Stock Analysis
No stock is ever a sure thing, but that doesn’t mean you can’t get asymptotically close to one. Following the announcement by VBI Vaccines, Inc.
Keep Reading →
November 14 - News, Stock Analysis
The US Food and Drug Administration (FDA) has recently cleared the Propeller platform of Propeller Health for use with GlaxoSmithKline Plc (ADR) (NYSE:GSK)'s Ellipta dry powder...
Keep Reading →
November 8 - News, Stock Analysis
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc.
Keep Reading →
October 26 - News, Stock Analysis
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit...
Keep Reading →
September 20 - News, Stock Analysis
Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in...
Keep Reading →
August 1 - Earnings Report, News, Tech
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp...
Keep Reading →
July 18 - Market Movers, News
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
Keep Reading →
June 13 - Hedge Fund Analysis, Hedge Funds
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated...
Keep Reading →
June 9 - News, Stock Analysis
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients...
Keep Reading →
June 8 - News, Stock Analysis
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Keep Reading →
June 8 - News, Stock Analysis
Although it isn't quite earnings season yet, volatility never sleeps. Investors and traders will always buy and sell on meaningful news and stocks will always move.
Keep Reading →
April 7 - Market Movers, News
Deerfield Management, a healthcare-focused fund managed by James E.
Keep Reading →
December 11 - Hedge Funds, News
Hedge funds have started submitting their 13F filings with the SEC, offering other investors a chance to look at their equity holdings as of the end of the first quarter.
Keep Reading →
April 24 - Hedge Funds, News
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks.
Keep Reading →
February 4 - News
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
Keep Reading →
September 9 - Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) remains committed to eradicating the deadly virus which has already claimed more than 2,000 lives in Western Africa and is considered as the...
Keep Reading →
September 8 - News
Companies around the world, who do business in China were keeping a close watch on the trial of the British company investigator, Peter Humphrey, and his American wife and...
Keep Reading →
August 10 - News
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
Keep Reading →
July 17 - News
Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar...
Keep Reading →
September 23 - News
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Keep Reading →
September 6 - News
In the financial world, there are many methods market participants can use to track the equity markets.
Keep Reading →
September 3 - News
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Keep Reading →
August 30 - News
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 22 - News
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Keep Reading →
August 13 - News
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
Keep Reading →
August 12 - News
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Keep Reading →
June 24 - News
